Literature DB >> 21623162

Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters.

Chui-Sun Yap1, Abigail L Peterson, Gastone Castellani, John M Sedivy, Nicola Neretti.   

Abstract

Mammalian c-Myc is a member of a small family of three related proto-oncogenic transcription factors. c-Myc has an unusually broad array of regulatory functions, which include roles in cell cycle and apoptosis, a variety of metabolic functions, cell differentiation, senescence, and stem cell maintenance. c-Myc modulates the expression of a very large number of genes, but the magnitude of the majority of the regulatory effects is only 2-fold or less. c-Myc can both activate and repress the promoters of its target genes. Identification of genes directly regulated by c-Myc has been an enduring question in the field. We report here microarray expression profiling of a high resolution time course of c-Myc induction, using fibroblast cells in which c-Myc activity can be modulated from null to physiological. The c-Myc transcriptome dataset presented is the largest reported to date with 4,186 differentially regulated genes (1,826 upregulated, 2,360 downregulated, 1% FDR). The gene expression patterns fit well with the known biological functions of c-Myc. We describe several novel findings and present tools for further data mining. Although the mechanisms of transcriptional activation by c-Myc are well understood, how c-Myc represses an even greater number of genes remains incompletely described. One mechanism involves the binding of c-Myc to other, positively acting transcription factors, and interfering with their activities. We identified rapid-response genes likely to be direct c-Myc targets, and analyzed the promoters of the repressed genes to identify transcription factors that could be targets of c-Myc repression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623162      PMCID: PMC3154366          DOI: 10.4161/cc.10.13.16249

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  69 in total

1.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles.

Authors:  Albin Sandelin; Wynand Alkema; Pär Engström; Wyeth W Wasserman; Boris Lenhard
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

Review 2.  Mechanisms of transcriptional repression by Myc.

Authors:  D Kleine-Kohlbrecher; S Adhikary; M Eilers
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 3.  The Oscar-worthy role of Myc in apoptosis.

Authors:  Natalie Meyer; Sam S Kim; Linda Z Penn
Journal:  Semin Cancer Biol       Date:  2006-07-14       Impact factor: 15.707

4.  Integration of biological networks and gene expression data using Cytoscape.

Authors:  Melissa S Cline; Michael Smoot; Ethan Cerami; Allan Kuchinsky; Nerius Landys; Chris Workman; Rowan Christmas; Iliana Avila-Campilo; Michael Creech; Benjamin Gross; Kristina Hanspers; Ruth Isserlin; Ryan Kelley; Sarah Killcoyne; Samad Lotia; Steven Maere; John Morris; Keiichiro Ono; Vuk Pavlovic; Alexander R Pico; Aditya Vailaya; Peng-Liang Wang; Annette Adler; Bruce R Conklin; Leroy Hood; Martin Kuiper; Chris Sander; Ilya Schmulevich; Benno Schwikowski; Guy J Warner; Trey Ideker; Gary D Bader
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

5.  Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif.

Authors:  J A Nye; J M Petersen; C V Gunther; M D Jonsen; B J Graves
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

8.  Transcriptional repression: the dark side of myc.

Authors:  Barbara Herkert; Martin Eilers
Journal:  Genes Cancer       Date:  2010-06

9.  The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry.

Authors:  Fionnuala Morrish; Nicola Neretti; John M Sedivy; David M Hockenbery
Journal:  Cell Cycle       Date:  2008-02-08       Impact factor: 4.534

Review 10.  The molecular mechanism of induced pluripotency: a two-stage switch.

Authors:  Wouter Scheper; Sjef Copray
Journal:  Stem Cell Rev Rep       Date:  2009-06-24       Impact factor: 5.739

View more
  20 in total

Review 1.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

2.  ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.

Authors:  A Dzikiewicz-Krawczyk; K Kok; I Slezak-Prochazka; J-L Robertus; J Bruining; M M Tayari; B Rutgers; D de Jong; J Koerts; A Seitz; J Li; B Tillema; J E Guikema; I M Nolte; A Diepstra; L Visser; J Kluiver; A van den Berg
Journal:  Leukemia       Date:  2017-03-23       Impact factor: 11.528

3.  ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells.

Authors:  Yaxin Sun; Beibei Sha; Wenjing Huang; Miaomiao Li; Shan Zhao; Yuan Zhang; Jie Yan; Zheng Li; Jingwen Tang; Peiyan Duan; Jianxiang Shi; Pei Li; Tao Hu; Ping Chen
Journal:  Apoptosis       Date:  2022-06-02       Impact factor: 5.561

4.  B-cell Receptor Signaling Induced Metabolic Alterations in Chronic Lymphocytic Leukemia Can Be Partially Bypassed by TP53 Abnormalities.

Authors:  Katarina Kluckova; Andrew J Clear; Annalisa D'Avola; Laura Z Rassenti; Thomas J Kipps; John G Gribben; John C Riches
Journal:  Hemasphere       Date:  2022-05-13

Review 5.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

Review 6.  Cellular MYCro economics: Balancing MYC function with MYC expression.

Authors:  David Levens
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

7.  The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities.

Authors:  Martin Montagne; Nicolas Beaudoin; David Fortin; Christine L Lavoie; Roscoe Klinck; Pierre Lavigne
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

8.  Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis.

Authors:  SungHee Park; Mattia Brugiolo; Martin Akerman; Shipra Das; Laura Urbanski; Adam Geier; Anil K Kesarwani; Martin Fan; Nathan Leclair; Kuan-Ting Lin; Leo Hu; Ian Hua; Joshy George; Senthil K Muthuswamy; Adrian R Krainer; Olga Anczuków
Journal:  Cell Rep       Date:  2019-11-26       Impact factor: 9.995

9.  Reverse engineering the neuroblastoma regulatory network uncovers MAX as one of the master regulators of tumor progression.

Authors:  Ricardo D'Oliveira Albanus; Rodrigo Juliani Siqueira Dalmolin; Mauro Antônio Alves Castro; Matheus Augusto de Bittencourt Pasquali; Vitor de Miranda Ramos; Daniel Pens Gelain; José Cláudio Fonseca Moreira
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

Review 10.  The Quest for Targets Executing MYC-Dependent Cell Transformation.

Authors:  Markus Hartl
Journal:  Front Oncol       Date:  2016-06-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.